BIOTECH CLINICAL RESEARCH
Turn Limited Resources Into Maximum Early-Stage Impact
Advance your Phase 1 trial with cost-effective clinical research, rapid timelines, and high-quality data you can trust.
Every Delay Costs More Than Time.
Biotech companies often operate with limited resources, making every dollar and every day critical. Without the right clinical research partners, you risk:
- Burning through capital before proving your therapy’s value.
- Facing delays that stall momentum and diminish investor confidence.
- Securing reliable clinical research studies that can withstand regulatory review.
The CRO Partner
Prioritizing Your Success
As a clinical research organization (CRO) trusted by more than 150 companies worldwide, we specialize in early-phase clinical trials that give Biotech companies the advantage:
- Pharmacology - SAD / MAD, DDI, PK/PD
- First-in-Human (FIH) Studies
- Cardiac Safety Studies
- dOMF Studies
- Bioanalytical Services
Trusted Clinical Research Center
Cost-Effective Execution
Proven strategies to maximize budget and preserve capital.
Fast Timelines
Rapid start-up and recruitment at our dedicated clinical trial unit.
Reliable Data
High-quality, submission-ready results from our expert clinical research specialists.
You need a CRO partner that understands the urgency of early development while protecting limited resources. At Axis, we structure our studies to help you stretch your budget, accelerate milestones, and generate the kind of reliable data that drives investor confidence and regulatory approval.
With a dedicated clinical research center, integrated bioanalytical services, and expert teams, we’re designed to help you move forward faster—without overspending or sacrificing data quality.
A Clinical Trial Unit Trusted by Leading Innovators











Accelerating Early-Phase Studies

Pharmacology Services
Move your program forward with confidence. From First-in-Human (FIH) and SAD/MAD to DDI and PK/PD studies, our early-phase clinical research specialists deliver accurate results quickly and cost-effectively.

Early TQT Studies / Cardiac Safety
Establish cardiac safety earlier in development with TQT studies conducted at our purpose-built clinical research center, leveraging seamless ECG integration and expert cardiovascular monitoring.

dOMF Studies
Saving valuable time helps save your budget. With dOMF studies, you gain early human data from fewer subjects, helping you preserve capital and make smarter development decisions faster.

hADME
Pharmacokinetics ADME studies done right with fast insight, high scientific rigour and regulatory ready results.

A Clinical Trial Unit Trusted

By Biotech Innovators
Clinical Research Center
- 200+ dedicated beds for healthy volunteer and patient studies
- Integrated bioanalytical lab services for end-to-end efficiency
- Experienced teams of clinical research specialists who manage every detail with precision
Why Biotech Companies Partner with Axis
Biotech innovators choose Axis because we understand the unique pressures of early-stage development—tight budgets, critical milestones, and the need for reliable results that build value early.
High-Enrolling US Site
Capital Optimization
Submission-Ready Data
End-to-End Expertise
Make Every Dollar and Every Day Count
Partner with Axis to run your biotech clinical trials efficiently, preserve capital, and create the data that increases asset value.
What Our Clients Say
Real results and strong relationships—straight from the teams we’ve worked alongside.
"AXIS has consistently delivered outstanding support as a Phase 1 site partner. Their ability to recruit and enroll subjects quickly and efficiently has been a key factor in keeping our timelines on track. The team is professional, responsive, and well-organized, ensuring the smooth execution of even the most complex pharmacology studies. We value their expertise and look forward to continued collaboration."
"We've worked with AXIS Clinicals USA on several Phase 1 studies, and their ability to quickly enroll subjects has been a huge advantage for us. They’re efficient, easy to work with, and always meet our timelines. Their team handles everything smoothly, which makes our job easier. We’re grateful for their support and look forward to working with them again."
"Partnering with AXIS has been a transformative experience for us. Their team deeply understands the complexities of pharmacology cardiac safety TQT projects and has been exceptionally responsive and proactive at every stage. What could have been a challenging process was made significantly smoother, with seamless coordination between clinical and bioanalysis under one roof, keeping timelines on track and delivering high-quality data."
"AXIS has been our long-time reliable partner for clinical research. Their team understands the challenges of developing 505(b)(2) products and has provided solid support throughout our clinical development program of studies. They’ve helped us stay on track and navigate a complex process with professionalism and quality data. I would recommend them to all of my industry contacts looking for a dependable CRO partner."
Your Path to Fast
Cost-Effective Biotech Early-Phase Trials
Every milestone begins with a plan. Here’s how to keep your clinical trial moving smoothly and on budget.

Schedule a
Consultation
Tell us about your compound,
goals, and funding milestones.

Get a Custom Proposal
& Trial Timeline
Receive a transparent plan with clear
costs, timelines, and endpoints.

Advance to Phase II
Quickly with Confidence
Receive the quality data you need to attract
investment and move to the next phase
Have questions or need expert support? Our team is here to help—reach out and let’s move forward together.